{"id":293964,"date":"2025-10-11T06:26:13","date_gmt":"2025-10-11T06:26:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/293964\/"},"modified":"2025-10-11T06:26:13","modified_gmt":"2025-10-11T06:26:13","slug":"groundbreaking-new-treatment-for-anxiety-and-depression","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/293964\/","title":{"rendered":"Groundbreaking new treatment for anxiety and depression"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/4K063J1_download_png\" width=\"288\" height=\"386\" alt=\"Professor Paul Glue is a finalist in this year's KiwiNet Awards.\"\/><\/p>\n<p class=\"photo-captioned__information\">\nProfessor Paul Glue is a finalist in this year&#8217;s KiwiNet Awards.<br \/>\nPhoto: SUPPLIED\n<\/p>\n<p paraeid=\"{3385cb0f-9d05-4cc5-bc39-1ffb18719051}{121}\" paraid=\"138359117\">One in four New Zealanders will experience some form of anxiety or depressive disorder in their lifetime.<\/p>\n<p>Of those, it&#8217;s reported that at least 30% won&#8217;t respond to traditional treatment therapies.<\/p>\n<p>Professor Paul Glue from Otago University is a finalist in this year&#8217;s KiwiNet Awards for his work in developing a drug that has been shown to help where others have failed.\u00a0<\/p>\n<p>With clinical trials and the approval process underway, he hopes to have the medication &#8211; a slow release form of ketamine &#8211; to market in less than three years.\u00a0<\/p>\n<p>Professor Glue talks to Mihingarangi about his research and not one &#8211; but two &#8211; groundbreaking discoveries.\u00a0<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/4KBMZA9_218252202_xl_jpg\" width=\"1050\" height=\"700\" alt=\"A digital concept of artificial intelligence with a human head on a hand.\"\/><\/p>\n<p class=\"photo-captioned__information\">\n<p>Photo: 123rf<\/p>\n","protected":false},"excerpt":{"rendered":"Professor Paul Glue is a finalist in this year&#8217;s KiwiNet Awards. Photo: SUPPLIED One in four New Zealanders&hellip;\n","protected":false},"author":3,"featured_media":293965,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[5157,3240,210,517,50,5158,5156,5154,5155,67,132,68],"class_list":{"0":"post-293964","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-mental-health","8":"tag-audio","9":"tag-current-affairs","10":"tag-health","11":"tag-mental-health","12":"tag-news","13":"tag-podcasts","14":"tag-public-radio","15":"tag-radio-new-zealand","16":"tag-rnz","17":"tag-united-states","18":"tag-unitedstates","19":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115354113946486862","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/293964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=293964"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/293964\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/293965"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=293964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=293964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=293964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}